(Q34130174)

31 July 2017

1 reference

title

Treatment options in the management of adolescent depression (English)

1 reference

31 July 2017

1 reference

Weller EB

1

1 reference

31 July 2017

Weller RA

series ordinal

2

1 reference

31 July 2017

language of work or name

1 reference

1 December 2000

1 reference

Journal of Affective Disorders

31 July 2017

published in

1 reference

31 July 2017

volume

61 Suppl 1

1 reference

31 July 2017

page(s)

23-28

1 reference

Fluoxetine for childhood anxiety disorders

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900286-X

7 January 2021

The cost of antidepressant overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900286-X

7 January 2021

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900286-X

7 January 2021

Depression in children

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900286-X

7 January 2021

Open fluoxetine treatment of mixed anxiety disorders in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900286-X

7 January 2021

Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900286-X

7 January 2021

Clinical effects of amitriptyline in adolescent depression. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900286-X

7 January 2021

Response to desipramine treatment in adolescent depression: a fixed-dose, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900286-X

7 January 2021

A randomized, controlled trial of amitriptyline in the acute treatment of adolescent major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900286-X

7 January 2021

Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900286-X

7 January 2021

Dysthymic disorder in clinically referred preschool children

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900286-X

7 January 2021

Imipramine in adolescent major depression: plasma level and clinical response

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900286-X

7 January 2021

Case study: two additional sudden deaths with tricyclic antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900286-X

7 January 2021

Controlled trial of a brief cognitive-behavioural intervention in adolescent patients with depressive disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900286-X

7 January 2021

10.1016/S0165-0327(00)00286-X

Identifiers

DOI

1 reference

31 July 2017

1 reference